ARCHIVES

Tykerb And Trastuzumab Showed Increase In PFS For HER2+ Breast Cancer In Study

This article is from The Cancer Letter archive.

Vol. 31 No. 5 | May 30, 2008

Download PDF Visit The Full Archive

Related Articles

FDA Working On New Ground Rules For “Adaptive” Clinical Trial Designs.

July 14, 2006

BSA Approves Provocative Questions RFA; NCI Announces Review of SAIC-Frederick, for caBIG Restructuring

June 24, 2011

NIH Director Calls For Lifting Federal Ban on Embryonic Stem Cell Research.

March 23, 2007

Concepts For Computer Support Services Ok’d By NCAB Committee

September 25, 1992

Ford To Resubmit Budget Slash Of $125 Million For NCI

January 3, 1975

In Brief: Interim Dean Henney Looking for Cancer Center Director; Shingleton Gets James Ewing Award

June 10, 1988